Does meloxicam contain hydrochloric acid (HCL)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Meloxicam Contain HCL (Hydrochloric Acid)?

No, meloxicam does not contain hydrochloric acid (HCL) as part of its chemical structure or formulation. Meloxicam is chemically defined as 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1-dioxide, an oxicam derivative NSAID 1.

Chemical Composition

  • Meloxicam is a standalone chemical entity that does not require or contain a hydrochloride salt form 1
  • The drug is a selective COX-2 inhibitor with a distinct molecular structure that includes benzothiazine and thiazole rings 2
  • Unlike some medications that are formulated as hydrochloride salts (such as hydroxocobalamin hydrochloride, naloxone hydrochloride, or pralidoxime chloride mentioned in antidote guidelines), meloxicam exists as a free base 3, 1

Formulation Characteristics

  • Meloxicam is available in oral tablets, oral suspension, and rectal suppository formulations 1
  • The drug is highly protein-bound (>99.5%) and undergoes hepatic metabolism to inactive metabolites 4
  • Standard dosing for arthritis is 7.5-15 mg once daily, with the drug's 20-hour half-life allowing for single daily administration 5, 4

Clinical Implications

  • The absence of HCL in meloxicam's formulation does not affect its efficacy as a COX-2 preferential NSAID 6, 2
  • Meloxicam demonstrates linear pharmacokinetics across its therapeutic dose range without requiring acid salt formation for absorption 4
  • The drug achieves nearly complete absorption regardless of the absence of hydrochloride salt formation 4

References

Research

Meloxicam.

Profiles of drug substances, excipients, and related methodology, 2020

Research

Meloxicam: a selective COX-2 inhibitor non-steroidal anti-inflammatory drug.

Expert opinion on investigational drugs, 1997

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A review of the clinical pharmacokinetics of meloxicam.

British journal of rheumatology, 1996

Guideline

Meloxicam Dosage and Administration for Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Meloxicam.

Expert opinion on pharmacotherapy, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.